Markets & Regulations

(elenlabs/iStock via Getty Images Plus)

Latest FDA COVID-19 news

By Jenni Spinner

As the pandemic continues to impact the globe, the agency has kept busy issuing EUAs for potential treatments, and cited sellers of unapproved treatments.

(ANDREI NIKOLAEV/iStock via Getty Images Plus)

People on the Move: December 2020

By Jenni Spinner

This month’s news about industry hires, promotions, acquisitions and other events includes Signant, PRA, Lonza, Bora Pharmaceuticals and other top firms.

(Artisanova/iStock via Getty Images Plus)

Advarra acquires Longboat

By Jenni Spinner

The clinical site services provider continues its series of strategic company purchases by bringing the Irish trial technologies firm under its umbrella.

(Nitin Chavan/iStock via Getty Images Plus)

FDA grants EUA for combo COVID-19 treatment

By Jenni Spinner

The agency has given the go-ahead for use of baricitinib in conjunction with remdesivir for treating patients hospitalized with severe cases of the virus.

(12963734/iStock via Getty Images Plus)

FDA COVID-19 news roundup this week

By Jenni Spinner

The federal agency has offered updates, advice and action regarding the COVID-19 pandemic, helping life-sciences professionals stay on top of developments.

(DonkeyWorx/iStock via Getty Images Plus)

Latest FDA updates on COVID-19 battle

By Jenni Spinner

As the pandemic maintains a grip on the globe, the federal agency continues to offer advice and take action to guide life-sciences professionals.

(RG-vc/iStock via Getty Images Plus)

Advarra purchases IntegReview IRB

By Jenni Spinner

The institutional review board services provider has acquired the AAHRPP-accredited central IRB, which specializes in early-phase research.

Follow us

Products

View more

Webinars